Human serum-resistant retroviral vector particles from galactosyl (α1–3) galactosyl containing nonprimate cell lines

[1]  C. Porter,et al.  Sensitization of rhabdo-, lenti-, and spumaviruses to human serum by galactosyl(alpha1-3)galactosylation , 1997, Journal of virology.

[2]  S. Loiler,et al.  Gene transfer to human cells using retrovirus vectors produced by a new polytropic packaging cell line , 1997, Journal of virology.

[3]  C. Wysocki,et al.  Development of amphotropic murine retrovirus vectors resistant to inactivation by human serum. , 1996, Human gene therapy.

[4]  C. Porter,et al.  Sensitization of cells and retroviruses to human serum by (alpha 1-3) galactosyltransferase. , 1996, Nature.

[5]  Y Takeuchi,et al.  High-titer packaging cells producing recombinant retroviruses resistant to human serum , 1995, Journal of virology.

[6]  E. Setter,et al.  A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody , 1995, The Journal of experimental medicine.

[7]  Y Takeuchi,et al.  Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell , 1994, Journal of virology.

[8]  J. Manning,et al.  Identification of immunodominant epitopes in Trypanosoma cruzi trypomastigote surface antigen-1 protein that mask protective epitopes. , 1994, Journal of immunology.

[9]  M. Suomalainen,et al.  Incorporation of homologous and heterologous proteins into the envelope of Moloney murine leukemia virus , 1994, Journal of virology.

[10]  K. B. Andersen.  A domain of murine retrovirus surface protein gp70 mediates cell fusion, as shown in a novel SC-1 cell fusion system , 1994, Journal of virology.

[11]  U. Galili,et al.  Differential host-dependent expression of alpha-galactosyl epitopes on viral glycoproteins: a study of eastern equine encephalitis virus as a model. , 1994, The Journal of general virology.

[12]  K. Cornetta,et al.  Infection of human cells with murine amphotropic replication-competent retroviruses. , 1993, Human gene therapy.

[13]  W. Anderson,et al.  Analysis of the functional and host range-determining regions of the murine ectropic and amphotropic retrovirus envelope proteins , 1993, Journal of virology.

[14]  L. Montagnier,et al.  Influence of carbohydrate moieties on the immunogenicity of human immunodeficiency virus type 1 recombinant gp160 , 1992, Journal of virology.

[15]  C. Goochee,et al.  The Oligosaccharides of Glycoproteins: Bioprocess Factors Affecting Oligosaccharide Structure and their Effect on Glycoprotein Properties , 1991, Bio/Technology.

[16]  D. Kinney,et al.  Mutational analysis of N-linked glycosylation sites of Friend murine leukemia virus envelope protein , 1991, Journal of virology.

[17]  S. Olofsson,et al.  Activity of herpes simplex virus type 1-specified glycoprotein C antigenic site II epitopes reversibly modulated by peripheral fucose or galactose units of glycoprotein oligosaccharides. , 1990, The Journal of general virology.

[18]  J. Stirling.  Immuno- and affinity probes for electron microscopy: a review of labeling and preparation techniques. , 1990, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[19]  L. Schofield.  The circumsporozoite protein of Plasmodium: a mechanism of immune evasion by the malaria parasite? , 1990, Bulletin of the World Health Organization.

[20]  Miller Ad,et al.  Improved Retroviral Vectors for Gene Transfer and Expression , 1989 .

[21]  A. Miller,et al.  Improved retroviral vectors for gene transfer and expression. , 1989, BioTechniques.

[22]  S. Goff,et al.  A safe packaging line for gene transfer: separating viral genes on two different plasmids , 1988, Journal of virology.

[23]  S. Shohet,et al.  Human natural anti-alpha-galactosyl IgG. II. The specific recognition of alpha (1----3)-linked galactose residues , 1985, The Journal of experimental medicine.

[24]  M. Martin,et al.  Envelope and long terminal repeat sequences of a cloned infectious NZB xenotropic murine leukemia virus , 1985, Journal of virology.

[25]  A. Khan.  Nucleotide sequence analysis establishes the role of endogenous murine leukemia virus DNA segments in formation of recombinant mink cell focus-forming murine leukemia viruses , 1984, Journal of virology.

[26]  I. Wilson,et al.  A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[27]  M. Miwa,et al.  Human T-cell leukaemia virus is not lysed by human serum , 1984, Nature.

[28]  K. Wise,et al.  Mycoplasma host-cell interactions resulting in chronic inflammation: acquisition of host antigens and other mechanisms. , 1981, Israel journal of medical sciences.

[29]  D. Baltimore,et al.  Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase , 1981, Journal of virology.

[30]  R. Schwarz,et al.  Carbohydrate-induced conformational changes of Semliki forest virus glycoproteins determine antigenicity. , 1980, Virology.

[31]  H. Müller-Eberhard,et al.  Lysis of oncornaviruses by human serum. Isolation of the viral complement (C1) receptor and identification as p15E , 1978, The Journal of experimental medicine.

[32]  R. Welsh.  Host cell modification of lymphocytic choriomeningitis virus and Newcastle disease virus altering viral inactivation by human complement. , 1977, Journal of immunology.

[33]  O. Goldring,et al.  Acquisition of human blood group antigens by Schistosoma mansoni. , 1976, Clinical and experimental immunology.

[34]  F. Jensen,et al.  Human serum lyses RNA tumour viruses , 1975, Nature.

[35]  F. Jensen,et al.  Lysis of oncornaviruses by human serum. , 1975, Bibliotheca haematologica.